The Null Hypothesis is a collaboration between CBMRT and leading biomedical journals, research institutions and research funders to get more non-positive results published, tracked and discovered - to better shape future research, reduce publication bias, and - ultimately - inform better treatment decisions. The initiative is built on three pillars - journals that actively seek and publish non-positive papers under the Null Hypothesis brand; institutions that actively encourage research staff to write-up non-positive papers; and funders who recognize and reward grantees who write-up and publish their work.
To date, the Null Hypothesis initiative has supported over 750 researchers from 200 different research institutions worldwide to publish their non-positive findings. CBMRT maintains a cross-journal online collection of Null Hypothesis articles at NullHypothesis.com.
BIOMEDICAL TRANSPARENCY SUMMITS - BMTS
CBMRT hosts an annual summit series, the Biomedical Transparency Summits, in the US and EU. These summits represent a unique opportunity for stakeholders in the research ecosystem to connect, collaborate and update on major aspects of research transparency. Representatives include stakeholders such as research funders and policy makers, government departments, technology developers, editors, publishers, industry leaders and academia. To learn more about our speakers, programs and participating organizations - click here.
CBMRT maintains an international ambassador network of researchers interested in promoting the write-up and publication of results at their own institution.
If you are a clinician, early-career researcher, PhD or Postdoc researcher or coordinator with an interest in enhancing research culture together, please join our network! Please contact email@example.com for more information.